Skip to Main content Skip to Navigation
Journal articles

An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis

Friederike Jönsson 1 Luc de Chaisemartin 2, 3 Vanessa Granger 2, 3 Aurélie Gouel-Chéron 1, 3 Caitlin Gillis 1 Qianqian Zhu 1, 2 Fadia Dib 3 Pascale Nicaise-Roland 3 Christelle Ganneau 4 Maria Hurtado-Nedelec 3 Catherine Paugam-Burtz 5, 6 Skander Necib 5, 6 Hawa Keita-Meyer 7, 8 Matthieu Le Dorze 9 Bernard Cholley 10 Olivier Langeron 11, 12 Laurent Jacob 13 Benoît Plaud 13 Marc Fischler 14 Caroline Sauvan 3 Marie-Therese Guinnepain 14 Philippe Montravers 3, 15 Michel Aubier 3, 15 Sylvie Bay 4 Catherine Neukirch 3, 15 Florence Tubach 16 Dan Longrois 3 Sylvie Chollet-Martin 3, 2, * Pierre Bruhns 1, *
* Corresponding author
1 Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology
2 Inflammation, Chimiokines et Immunopathologie [Châtenay-Malabry]
3 AP-HP - Hôpital Bichat - Claude Bernard [Paris]
4 Chimie des Biomolécules - Chemistry of Biomolecules
5 Hôpital Beaujon
6 UPD7 - Université Paris Diderot - Paris 7
7 Hopital Louis Mourier - AP-HP [Colombes]
8 REMES - Recherche Clinique ville-hôpital, Méthodologies et Société
9 Hôpital Lariboisière
10 HEGP - Hôpital Européen Georges Pompidou [APHP]
11 CHU Pitié-Salpêtrière [AP-HP]
12 Histopathologie humaine et Modèles animaux
13 Hôpital Saint-Louis
14 Hôpital Foch [Suresnes]
15 Lab Excellence Inflamex
16 iPLESP - Institut Pierre Louis d'Epidémiologie et de Santé Publique
Abstract : Anaphylaxis is a systemic acute hypersensitivity reaction that is considered to depend on allergen-specific immunoglobulin E (IgE) antibodies and histamine release by mast cells and basophils. Nevertheless, allergen-specific IgG antibodies have been proposed to contribute when the allergen is an abundant circulating large molecule, e.g., after infusions of therapeutic antibodies or dextran. Data from animal models demonstrate a pathway involving platelet-activating factor (PAF) release by monocytes/macrophages and neutrophils activated via their Fc gamma receptors (FcγRs). We hypothesized that such a pathway may also apply to small drugs and could be responsible for non-IgE-mediated anaphylaxis and influence anaphylaxis severity in humans. We prospectively conducted a multicentric study of 86 patients with suspected anaphylaxis to neuromuscular-blocking agents (NMBAs) during general anesthesia and 86 matched controls. We found that concentrations of anti-NMBA IgG and markers of FcγR activation, PAF release, and neutrophil activation correlated with anaphylaxis severity. Neutrophils underwent degranulation and NETosis early after anaphylaxis onset, and plasma-purified anti-NMBA IgG triggered neutrophil activation ex vivo in the presence of NMBA. Neutrophil activation could also be observed in patients lacking evidence of classical IgE-dependent anaphylaxis. This study supports the existence of an IgG-neutrophil pathway in human NMBA-induced anaphylaxis, which may aggravate anaphylaxis in combination with the IgE pathway or underlie anaphylaxis in the absence of specific IgE. These results reconcile clinical and experimental data on the role of antibody classes in anaphylaxis and could inform diagnostic approaches to NMBA-induced acute hypersensitivity reactions.
Document type :
Journal articles
Complete list of metadatas

Cited literature [104 references]  Display  Hide  Download
https://hal-pasteur.archives-ouvertes.fr/pasteur-02294649
Contributor : Friederike Jönsson <>
Submitted on : Monday, September 23, 2019 - 3:59:28 PM
Last modification on : Thursday, December 10, 2020 - 3:42:54 AM
Long-term archiving on: : Sunday, February 9, 2020 - 11:41:03 AM

File

Vignette du document
NASA_manuscript_revised_final ...
Files produced by the author(s)

Identifiers

Collections

PASTEUR | CNRS | IPLESP | SORBONNE-UNIVERSITE | UNIV-PARIS7 | SU-MEDECINE | USPC | UNIV-PARIS | SU-TI

Citation

Friederike Jönsson, Luc de Chaisemartin, Vanessa Granger, Aurélie Gouel-Chéron, Caitlin Gillis, et al.. An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis. Science Translational Medicine, American Association for the Advancement of Science, 2019, 11 (500), pp.eaat1479. ⟨10.1126/scitranslmed.aat1479⟩. ⟨pasteur-02294649⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

582

Files downloads

1001